Cite
HARVARD Citation
Yu, H. et al. (2015). Differences in the survival of patients with recurrent versus de novo metastatic KRAS‐mutant and EGFR‐mutant lung adenocarcinomas. Cancer. 121 (12), pp. 2078-2082. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yu, H. et al. (2015). Differences in the survival of patients with recurrent versus de novo metastatic KRAS‐mutant and EGFR‐mutant lung adenocarcinomas. Cancer. 121 (12), pp. 2078-2082. [Online].